Funder
NIH
National Cancer Institute
CPRIT
V Foundation
Eastern Cooperative Oncology Group
Burroughs Wellcome Fund
Reference45 articles.
1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Teras;CA Cancer J Clin,2016
2. Past, present, and future of rituximab—the world’s first oncology monoclonal antibody therapy;Pierpont;Front Oncol,2018
3. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma;Tilly;N Engl J Med,2022
4. Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, perspective, single-arm, phase 2 study;Salles;Lancet Oncol,2020
5. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma;Wilson;Nat Med,2015